Integrative Approaches to Understanding Genetic Basis of Neuropsychiatric Diseases

了解神经精神疾病遗传基础的综合方法

基本信息

  • 批准号:
    10224033
  • 负责人:
  • 金额:
    $ 49.54万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-05-17 至 2023-05-31
  • 项目状态:
    已结题

项目摘要

Project Summary Identifying the susceptibility genes and variants of neuro-psychiatric diseases will not only contribute to our understanding of these diseases, but also point to potential therapeutic targets. Genome-wide association studies (GWAS) are commonly used to study complex diseases, and have been highly successful in a range of disorder, for instance, more than 100 loci have been associated with the risk of Schizophrenia through GWAS. Nevertheless, in most cases, we do not know the biological mechanisms underlying disease associated loci, because the causal variants and genes are obscured by linkage disequilibrium (LD) and by the difficulty of interpreting functional effects of most genetic variants. The goal of this project is to develop novel statistical methods for integrative analysis of genetic data of neuropsychiatric diseases to better understand the underlying genes and biological processes. (1) We will develop a method to integrate expression QTL (eQTL) data with GWAS. Our method extends the popular Transcriptome-Wise Association Studies (TWAS). TWAS aims to discover risk genes, by effectively assessing the correlation of eQTLs of a gene with the phenotype of interest. TWAS has many advantages over standard single variant-based analysis, e.g. it reduces multiple testing burden and provides biological contexts of associations. However, current TWAS methods are susceptible to false positive findings. We will develop a rigorous statistical framework to control false discoveries by accounting for pleiotropic effects of variants. (2) Fine-mapping is the statistical approach to identifying causal variants in disease-associated loci. Current fine- mapping methods, however, are often not able to narrow down specific causal variants. Our approach is based on the observation that allelic heterogeneity (AH), i.e. many variants disrupting the same gene, is common. So we can leverage AH to identify risk genes, borrowing the statistical framework of fine-mapping. (3) Researchers have developed tools to joint analyze multiple traits to improve the power of gene discovery and to identify causal risk factors of diseases. Existing approaches, however, are often based on pair-wise analysis. We will develop a powerful statistical framework to better understand common biological processes driving genetic relationships among multiple traits. Additionally, we will develop more accurate Mendelian Randomization (MR) method to identify causal relationship among traits. (4) A key component of our effort is the development of user-friendly software that could benefit the broad psychiatric genetics community.
项目摘要 识别神经精神疾病的易感基因和变异不仅有助于我们的 对这些疾病的了解,也指出了潜在的治疗目标。全基因组关联 研究(GWAS)通常用于研究复杂疾病,并在一系列研究中非常成功 例如,通过GWA,100多个基因座与精神分裂症的风险有关。 然而,在大多数情况下,我们不知道疾病相关基因座背后的生物学机制, 因为因果变异和基因被连锁不平衡(LD)和困难的 解释大多数遗传变异的功能效应。 该项目的目标是开发新的统计方法,用于综合分析儿童的遗传数据 神经精神疾病,以更好地了解潜在的基因和生物过程。(1)我们会 开发了一种将表达QTL(EQTL)数据与GWAS整合的方法。我们的方法扩展了流行的 转录组-智者联合研究(TWAS)。Twas的目标是通过有效地评估发现风险基因 基因的eQTL与感兴趣的表型的相关性。与标准相比,Twas有许多优势 基于单个变量的分析,例如,它减少了多个测试负担,并提供了 联想。然而,目前的TWA法容易出现假阳性结果。我们将开发一种 严格的统计框架,通过考虑变异的多效性效应来控制错误发现。(2) 精细作图是识别疾病相关基因座因果变异的统计方法。目前很好- 然而,作图方法往往不能缩小特定的因果变量范围。我们的方法是基于 根据观察,等位基因异质性(AH),即许多变异破坏同一基因,是常见的。所以 我们可以借用精细图谱的统计框架,利用AH来识别风险基因。(3) 研究人员已经开发出工具来联合分析多个性状,以提高基因发现和 识别疾病的致病危险因素。然而,现有的方法通常是基于成对的 分析。我们将开发一个强大的统计框架,以更好地了解常见的生物过程 驱动多个性状之间的遗传关系。此外,我们还将开发更精确的孟德尔语言 确定性状之间因果关系的随机化(MR)方法。(4)我们努力的一个关键组成部分是 开发用户友好的软件,使广泛的精神病学遗传学社区受益。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Xin He其他文献

Xin He的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Xin He', 18)}}的其他基金

Discovery and interrogation of genetic regulatory variation impacting Atrial Fibrillation risk
影响心房颤动风险的基因调控变异的发现和询问
  • 批准号:
    10593080
  • 财政年份:
    2022
  • 资助金额:
    $ 49.54万
  • 项目类别:
Refining mutation rates and measures of purifying selection with an application to understanding the impact of non-coding variation on neuropsychiatric diseases
改进突变率和纯化选择的措施,并应用于了解非编码变异对神经精神疾病的影响
  • 批准号:
    10245296
  • 财政年份:
    2020
  • 资助金额:
    $ 49.54万
  • 项目类别:
Refining mutation rates and measures of purifying selection with an application to understanding the impact of non-coding variation on neuropsychiatric diseases
改进突变率和纯化选择的措施,并应用于了解非编码变异对神经精神疾病的影响
  • 批准号:
    10442570
  • 财政年份:
    2020
  • 资助金额:
    $ 49.54万
  • 项目类别:
Refining mutation rates and measures of purifying selection with an application to understanding the impact of non-coding variation on neuropsychiatric diseases
改进突变率和纯化选择的措施,并应用于了解非编码变异对神经精神疾病的影响
  • 批准号:
    10058223
  • 财政年份:
    2020
  • 资助金额:
    $ 49.54万
  • 项目类别:
Refining mutation rates and measures of purifying selection with an application to understanding the impact of non-coding variation on neuropsychiatric diseases
改进突变率和纯化选择的措施,并应用于了解非编码变异对神经精神疾病的影响
  • 批准号:
    10665606
  • 财政年份:
    2020
  • 资助金额:
    $ 49.54万
  • 项目类别:
Integrative Approaches to Mapping Susceptibility Genes of Complex Neuropsychiatric Disorders
绘制复杂神经精神疾病易感基因的综合方法
  • 批准号:
    9311685
  • 财政年份:
    2017
  • 资助金额:
    $ 49.54万
  • 项目类别:
Integrative Approaches to Understanding Genetic Basis of Neuropsychiatric Diseases
了解神经精神疾病遗传基础的综合方法
  • 批准号:
    10413982
  • 财政年份:
    2017
  • 资助金额:
    $ 49.54万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 49.54万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 49.54万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 49.54万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 49.54万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 49.54万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 49.54万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 49.54万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 49.54万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 49.54万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 49.54万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了